2.240 RASAGILINE IMPROVES THE QUALITY OF SLEEP IN PATIENTS WITH PARKINSON'S DISEASE: RESULTS OF THE RASAGILINE EFFECT ON SLEEP TRIAL (REST)
β Scribed by M. Panisset; S. Chouinard
- Book ID
- 117754933
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 77 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Most Parkinson's patients complain about sleep problems. The subjective effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on nocturnal disabilities and sleep quality was elucidated by the recently established Parkinson's disease sleep scale (PDSS). The DBS-treated group obtaine
## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase typeβB inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef